On Apr. 24, 2014, the U.S. Centers for Disease Control and Prevention (CDC) estimated that vaccinations prevent more…
On Apr. 1, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had expanded the approved…
On Feb. 28, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
In 2014, the World Health Organization (WHO) reported that largest outbreak of Ebola in history had occurred, and…
On Aug. 1, 2014, the U.S. Centers for Disease Control and Prevention (CDC) initiated the Global Heath Security…
On Dec. 26, 2013, a 2-year-old boy in the remote Guinean village of Meliandou fell ill with a…
On Dec. 20, 2013, the U.S. Centers for Disease Control and Prevention (CDC) published guidance for HBV protection…
On Dec. 16, 2013, the Centers for Disease Control and Prevention (CDC) was informed by Merck that the…
On Nov. 28, 2013 “Project Tycho,” was a mammoth study that tracked nearly 88 million cases of disease…
On Nov. 15, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use…
On Sept. 10, 2013, the National Vaccine Advisory Committee released revised “Standards for Adult Immunization Practice.” While previous…
On Aug. 16, 2013, GSK announced it had received approval from the US Food and Drug Administration’s (FDA)…
On Aug. 1, 2013, Novartis announced the U.S. Food and Drug Administration (FDA) had approved Menveo (Meningococcal [Groups…
On Jul. 19, 2013, the U.S. Centers for Disease Control and Prevention (CDC) issued updated recommendations for use…
On Jun. 28, 2013, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate…
On Jun. 20, 2013, the Advisory Committee on Immunization Practices (ACIP) voted 13 to 0, in favor of…
On Jun. 14, 2013, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
On Jun. 10, 2013, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
On May 17, 2013, the World Health Organization (WHO) announced that the yellow fever ‘booster’ vaccination given ten…
On Apr. 25, 2013, the Global Polio Eradication Initiative (GPEI) announced a comprehensive six-year plan, the first plan…
On Mar. 26, 2013, GlaxoSmithKline and the Texas A&M University System announced that the U.S. Department of Health…
On Mar. 16, 2013, the U.S. Patent and Trademark Office (USPTO) implemented the first inventor to file (FITF)…
On Feb. 22, 2013, the Advisory Committee on Immunization Practices (ACIP) recommended that unvaccinated pregnant women receive a…
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted to recommend use of HibMenCY (Menhibrix, GlaxoSmithKline),…
On Oct. 24, 2012, the Immunization Practices Advisory Committee (ACIP) voted 14-0 with one abstention to recommend that…
On Oct. 4, 2012, Takeda Pharmaceutical and LigoCyte Pharmaceuticals jointly announced that Takeda’s wholly-owned subsidiary, Takeda America Holdings…
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
On Jun. 5, 2012, the U.S. Department of Health and Human Services (HHS) Office of the Inspector General…